Sebastian Liebau
Papers
1
Total Citations
16
H-Index
1
About
Sebastian Liebau is a leading clinical researcher in radiation oncology, with a primary focus on advancing stereotactic body radiation therapy (SBRT) for prostate cancer. His most cited work, a 2017 German bi-center feasibility trial on hypo-fractionated SBRT for localized prostate cancer, established a critical proof-of-concept for delivering ultra-high-dose radiation in just a few treatment sessions. This study demonstrated that a five-fraction regimen could be safely administered in a multi-institutional setting, paving the way for shorter, more patient-friendly treatment protocols without compromising tumor control. With 16 citations, this work has helped shift clinical practice toward extreme hypo-fractionation, reducing overall treatment time from weeks to days. Liebau’s contributions are particularly notable for their focus on minimizing side effects while maintaining efficacy—a key priority in prostate cancer management. His research bridges the gap between technical feasibility and real-world clinical application, offering patients a non-invasive, convenient alternative to conventional radiotherapy. For students and researchers, Liebau’s work exemplifies how rigorous trial design can translate into meaningful improvements in cancer care.
Research Focus
Key Achievements
Top Papers
- 1